로딩 중…
지수 로딩 중…
Vaxcyte, Inc.
PCVX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$51.44+1.52%
2026-06-18
Price Chart
Vaxcyte, Inc.+54.01%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $7.43B |
| Revenue | $0.00 |
| Net Income | $-947M |
| Total Assets | $3.35B |
| Net Assets | $3.00B |
| Value | |
| P/B | 2.48x |
| FCF Yield | -10.39% |
| Profitability | |
| ROE | -31.59% |
| ROA | -28.27% |
| Financial Health | |
| Debt Ratio | 11.76% |
| Total Debt | $116M |
| FCF | $-772M |
| Cash | $261M |
| Current Ratio | 7.49x |
| Performance | |
| 1Y Return | 54.01% |
| 1M Return | 5.45% |
| From 52W High | -20.86% |
| 1Y MDD | -58.73% |
| Trading | |
| Volume | 2,255,882 shares |
| Trading Value | $117M |
| Per Share | |
| EPS | $-5.63 |
| BPS | $19.73 |